We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Star-Shaped Polymers Kill Antibiotic Resistant Bacteria

By HospiMedica International staff writers
Posted on 05 Oct 2016
Image: A bacteria cell before (L) and after treatment (R) with star-shaped polymers (Photo courtesy of UNIMELB).
Image: A bacteria cell before (L) and after treatment (R) with star-shaped polymers (Photo courtesy of UNIMELB).
A new study suggests that structurally nanoengineered antimicrobial peptide polymers (SNAPPs) could provide a low-cost and effective antimicrobial agent against multidrug resistant (MDR) bacteria.

Developed by researchers at the University of Melbourne (UNIMELB; Parkville, Australia), the star-shaped SNAPP is extremely effective at killing Gram-negative bacteria while being non-toxic to the body’s own cells, thanks to its unique antimicrobial activity. SNAPPs induce cell death by a multimodal mechanism that combines outer membrane destabilization, unregulated ion movement across the cytoplasmic membrane, and induction of the apoptotic-like death pathway.

The SNAPPs exhibited sub-μM activity against all Gram-negative bacteria tested, including the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter, Pseudomonas aeruginosa and Enterobacter) pathogens and other colistin-resistant and MDR (CMDR) pathogens, while demonstrating low toxicity. In addition, the researchers did not observe any resistance acquisition by A. baumannii (including the CMDR strain) to SNAPPs. The study was published on September 12, 2016, in Nature Microbiology.

“It is estimated that the rise of superbugs will cause up to ten million deaths a year by 2050. In addition, there have only been one or two new antibiotics developed in the last 30 years,” concluded senior author Professor Greg Qiao, PhD, of the department of chemical and biomolecular engineering, and colleagues. “Overall, SNAPPs show great promise as low-cost and effective antimicrobial agents, and may represent a weapon in combating the growing threat of MDR Gram-negative bacteria.”

Antimicrobial polymers are engineered to mimic peptides used by the immune systems of living things to kill bacteria. Typically, they are produced by attaching or inserting an active antimicrobial agent onto a polymer backbone via an alkyl or acetyl linker. The use of antimicrobial polymers may enhance the efficiency and selectivity of common antimicrobial agents, while decreasing associated environmental hazards since they are generally nonvolatile and chemically stable.

Related Links:
University of Melbourne


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Instrument Cabinet
TRZY-068
New
Short Phlebotomy Cart
MSWA-3469-WHT

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more